Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-029216

NEOGENOMICS INC · NEO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jennifer Balliet
Officer — VP and Chief Culture Officer
Period of report
Apr 28, 2017
Accepted (ET)
May 2, 2017 · 4:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001077183

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stockholding———13,383D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F5$7.52Apr 28, 2017A60,000AApr 28, 2018Apr 28, 2022Common Stock60,00060,000D
Stock Option (Right to Buy)F1$3.76holding———Apr 16, 2014Apr 16, 2018Common Stock7,5007,500D
Stock Option (Right to Buy)F2$3.45holding———Mar 5, 2015Mar 5, 2019Common Stock15,00015,000D
Stock Option (Right to Buy)F3$4.78holding———May 4, 2016May 4, 2020Common Stock120,000120,000D
Stock Option (Right to Buy)F4$7.15holding———Apr 20, 2017Apr 20, 2021Common Stock50,00050,000D

Explanation of responses